A study funded by the National Institute Child Health and Human Development shows that anticholinergic drugs and onabotulinumtoxinA injections produce comparable results in women with urgency urinary incontinence. Choice of therapy, say the researchers, should take into consideration route of administration and adverse effect profiles.
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Tebipenem HBr cUTI trial ends early after meeting efficacy goals
May 28th 2025GSK and Spero Therapeutics announced that the phase 3 PIVOT-PO trial for tebipenem HBr, a potential first oral carbapenem for cUTIs in the United States, was stopped early because of positive efficacy results.
Read More